RecruitingNCT07295236

Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak

Prospective Observational Study on Endo-vac Therapy for Esophago-jejunal Anastomotic Leak


Sponsor

Ukrainian Society of Clinical Oncology

Enrollment

100 participants

Start Date

Dec 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed esophago-jejunal anastomotic leakage. The main outcomes to be investigated are the following: Primary endpoint: mortality rate Secondary endpoints: morbidity rate, time from AL diagnosis to discharge, patients satisfactory rate.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study looks at how well a vacuum-based therapy (Endo-VAC) works in treating leaks that form at the surgical connection in the digestive tract after stomach removal surgery. **You may be eligible if...** - You developed a leak at a surgical connection (esophago-jejunal anastomosis) after surgery - The leak affects less than 50% of the connection's circumference - You are medically stable at the time of the leak diagnosis and do not need emergency surgery **You may NOT be eligible if...** - You are medically unstable or require emergency surgery to address the leak - You have a large or complete leak at the surgical connection - Other specific medical conditions make this treatment unsafe for you Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Cancer Institute

Kyiv, Ukraine

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07295236